Jaguar Health, Inc. (JAGX)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 3 signals for Jaguar Health, Inc.. Most notable: 2026-06-25: Filed 8-K disclosing material agreement; 2026-07-14: Filed 8-K disclosing material agreement; 2026-09-15: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-11 | MICEK JOHN | director | A | 7,377 | 0 | $0 |
| 2025-12-11 | King Steven R. | officer | A | 11,740 | 0 | $0 |
| 2025-12-11 | Wolin Jonathan S. | officer | A | 11,740 | 0 | $0 |
| 2025-12-11 | CONTE LISA A | director | A | 28,592 | 0 | $0 |
| 2025-12-11 | Chaturvedi Pravin R | officer | A | 11,740 | 0 | $0 |
| 2025-12-11 | BOCHNOWSKI JAMES J | director | A | 6,363 | 0 | $0 |
| 2025-12-11 | Siegel Jonathan B. | director | A | 7,377 | 0 | $0 |
| 2025-12-11 | Jayasuriya Anula | director | A | 5,870 | 0 | $0 |
| 2025-12-11 | Lizak Carol R. | officer | A | 11,740 | 0 | $0 |
| 2025-05-17 | King Steven R. | officer | M | 1 | — | — |
| 2025-05-17 | CONTE LISA A | director | M | 2 | — | — |
| 2024-10-08 | Lizak Carol R. | officer | A | 4,280 | 0 | $0 |
| 2024-10-08 | Chaturvedi Pravin R | officer | A | 4,922 | 0 | $0 |
| 2024-10-08 | Wolin Jonathan S. | officer | A | 4,922 | 0 | $0 |
| 2024-10-08 | CONTE LISA A | director | A | 16,503 | 0 | $0 |
| 2024-10-08 | King Steven R. | officer | A | 4,922 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-21 8-K
- 2026-09-18 PRE 14A
- 2026-09-15 8-K
- 2026-09-15 8-K
- 2026-09-04 8-K
- 2026-09-03 424B5
- 2026-08-21 424B3
- 2026-08-19 8-K
- 2026-08-19 10-Q
- 2026-08-14 EFFECT
- 2026-08-14 NT 10-Q
- 2026-08-11 POS AM
- 2026-08-03 DEF 14A
- 2026-07-27 424B3
- 2026-07-27 424B3
- 2026-07-24 EFFECT
- 2026-07-24 EFFECT
- 2026-07-24 PRE 14A
- 2026-07-24 S-1/A
- 2026-07-16 S-1